# A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers

> **NCT00851383** · PHASE1 · COMPLETED · sponsor: **International AIDS Vaccine Initiative** · enrollment: 56 (actual)

## Conditions studied

- HIV
- HIV Infections

## Interventions

- **BIOLOGICAL:** Ad35-GRIN/ENV
- **BIOLOGICAL:** Ad35-GRIN

## Key facts

- **NCT ID:** NCT00851383
- **Lead sponsor:** International AIDS Vaccine Initiative
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2012-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00851383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00851383, "A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00851383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*